Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin-clavulanate in Acute Otitis Media
NCT01244581Phase 3Completed
- Sponsor
- University of Oulu
- Start
- Sep 1999
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute otitis media (AOM) comparing Amoxicillin-clavulanate with Placebo (2 arms). Primary endpoint: Time to disappearance of middle ear effusion at 60 days. Started Sep 1999; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT01244581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244581.